Biopharma companies develop medicines, vaccines and advanced therapies to prevent, treat and manage disease. The sector spans drug discovery, clinical development, manufacturing and commercialisation across a wide range of therapeutic areas.
This category includes companies working on:
Browse 134 UK biopharma companies below.
Cannabinoid medicines, neuroscience and oncology drug development
Jazz Pharmaceuticals is a global biopharmaceutical company focused on medicines for neuroscience and oncology. Its UK operations, centred at Kent Science Park in Sittingbourne,…
Pharmaceutical company in cardiometabolic, oncology, and immunology
Eli Lilly and Company is a multinational pharmaceutical company with UK operations headquartered in Basingstoke and an R&D site in Bracknell. Founded in 1876, Lilly's UK affiliate…
AI-enabled small molecule drug discovery
PharmEnable is a Cambridge-based drug discovery company developing novel small molecule therapeutics for targets that are inaccessible to biologics, including intracellular…
Specialist vaccine development and GMP manufacturing in Scotland
Valneva Scotland Limited is the UK manufacturing and R&D subsidiary of Valneva SE, a specialty vaccine company. Operating from an MHRA-authorised GMP facility in Livingston, the…
Defined live bacterial consortia for oncology and inflammatory bowel disease
Microbiotica is a clinical-stage biopharmaceutical company developing oral live biotherapeutic products comprising defined consortia of gut commensal bacterial strains. Candidate…
Generic, branded and biosimilar medicines across global therapeutic areas
Viatris UK Healthcare is the UK subsidiary of Viatris Inc., a global pharmaceutical company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division. Operating…
Global influenza vaccine leader with major UK manufacturing in Liverpool
CSL Seqirus is one of the world's largest influenza vaccine companies, operating the only injectable influenza vaccine manufacturing facility in the UK at Speke, Liverpool. The…
Inhaled interferon beta therapy for severe viral lung infections
Synairgen is a clinical-stage biopharmaceutical company developing an inhaled formulation of interferon beta as a broad-spectrum antiviral therapy for severe respiratory viral…
VHH single-domain antibody therapeutics for companion animals and livestock
272Bio is a biotechnology company developing biotherapeutic treatments for animal health applications across livestock and companion animals. The company applies novel antibody…
Veterinary pharmaceuticals developed and manufactured in Northern Ireland
Norbrook Laboratories is a vertically integrated veterinary pharmaceutical company developing, manufacturing and distributing medicines for farm and companion animals. Operating…
Antibody immunotherapy targeting toxic tau for neurodegenerative disease
TauC3 Biologics is a preclinical biopharmaceutical company developing an antibody-based immunotherapy that targets tauC3, a toxic, truncated form of the tau protein implicated in…
Clinical-stage company developing treatments for cancer cachexia and muscle wasting
Actimed Therapeutics is a clinical-stage specialty pharma developing treatments for cancer cachexia and muscle wasting disorders, areas with significant unmet need and no globally…